CRNX
Crinetics Pharmaceuticals Inc Earnings
$30.55
Earnings Summary
Revenue | $0.36Mn |
Net Profits | $-96.77Mn |
Net Profit Margins | -26807.2% |
Crinetics Pharmaceuticals Inc’s revenue fell -43.59% since last year same period to $0.36Mn in the Q1 2025. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated +Inf% jump in its revenue since last 3-months.
Crinetics Pharmaceuticals Inc’s net profit fell -44.59% since last year same period to $-96.77Mn in the Q1 2025. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated -20.07% fall in its net profits since last 3-months.
Crinetics Pharmaceuticals Inc’s net profit margin fell -156.34% since last year same period to -26807.2% in the Q1 2025. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.1 |
EPS Estimate Current Year | -1.1 |
Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -1.1 - a -15.51% fall from last quarter’s estimates.
Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -1.1.
Key Ratios
Earning Per Share (EPS) | 0 |
Crinetics Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2025. This indicates that the Crinetics Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-08 | -0.95 | -1.04 | -9.21% |
2025-08-08 | -1.1 | 0 | 100% |
